Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias



Makela, Eleonora, Pavic, Karolina, Varila, Taru, Salmenniemi, Urpu, Loyttyniemi, Eliisa, Nagelli, Srikar G, Ammunet, Tea, Kahari, Veli-Matti, Clark, Richard E ORCID: 0000-0002-1261-3299, Elo, Laura L
et al (show 4 more authors) (2021) Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias. CLINICAL CANCER RESEARCH, 27 (10). 2848 - 2860.

[img] Text
paper206 NOCIVA Author accepted version 210217.docx - Accepted Version

Download (172kB)
Item Type: Article
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 19 Mar 2021 11:03
Last Modified: 11 Aug 2022 04:13
DOI: 10.1158/1078-0432.CCR-20-3679
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3117749